medmix AG (SWX:MEDX)

medmix AG Statistics

Total Valuation

medmix AG has a market cap or net worth of CHF 377.58 million. The enterprise value is 596.08 million.

Market Cap	377.58M
Enterprise Value	596.08M

Important Dates

The next estimated earnings date is Thursday, February 26, 2026.

Earnings Date	Feb 26, 2026
Ex-Dividend Date	Apr 25, 2025

Share Statistics

medmix AG has 40.82 million shares outstanding. The number of shares has increased by 0.47% in one year.

Current Share Class	40.82M
Shares Outstanding	40.82M
Shares Change (YoY)	+0.47%
Shares Change (QoQ)	+7.63%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	22.13%
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	26.07
PS Ratio	0.81
PB Ratio	0.88
P/TBV Ratio	7.87
P/FCF Ratio	7.30
P/OCF Ratio	4.27
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.71, with an EV/FCF ratio of 11.53.

EV / Earnings	-102.77
EV / Sales	1.27
EV / EBITDA	8.71
EV / EBIT	36.80
EV / FCF	11.53

Financial Position

The company has a current ratio of 1.57, with a Debt / Equity ratio of 0.74.

Current Ratio	1.57
Quick Ratio	1.08
Debt / Equity	0.74
Debt / EBITDA	4.33
Debt / FCF	6.20
Interest Coverage	1.92

Financial Efficiency

Return on equity (ROE) is -1.13% and return on invested capital (ROIC) is 1.73%.

Return on Equity (ROE)	-1.13%
Return on Assets (ROA)	1.38%
Return on Invested Capital (ROIC)	1.73%
Return on Capital Employed (ROCE)	2.80%
Revenue Per Employee	175,516
Profits Per Employee	-2,175
Employee Count	2,684
Asset Turnover	0.47
Inventory Turnover	3.56

Taxes

In the past 12 months, medmix AG has paid 600,000 in taxes.

Income Tax	600,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -7.22% in the last 52 weeks. The beta is 0.91, so medmix AG's price volatility has been similar to the market average.

Beta (5Y)	0.91
52-Week Price Change	-7.22%
50-Day Moving Average	9.87
200-Day Moving Average	10.90
Relative Strength Index (RSI)	48.16
Average Volume (20 Days)	101,710

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, medmix AG had revenue of CHF 468.10 million and -5.80 million in losses. Loss per share was -0.14.

Revenue	468.10M
Gross Profit	161.60M
Operating Income	21.90M
Pretax Income	-4.50M
Net Income	-5.80M
EBITDA	63.80M
EBIT	21.90M
Loss Per Share	-0.14

Balance Sheet

The company has 108.40 million in cash and 320.50 million in debt, giving a net cash position of -212.10 million or -5.20 per share.

Cash & Cash Equivalents	108.40M
Total Debt	320.50M
Net Cash	-212.10M
Net Cash Per Share	-5.20
Equity (Book Value)	430.40M
Book Value Per Share	10.39
Working Capital	97.10M

Cash Flow

In the last 12 months, operating cash flow was 88.40 million and capital expenditures -36.70 million, giving a free cash flow of 51.70 million.

Operating Cash Flow	88.40M
Capital Expenditures	-36.70M
Free Cash Flow	51.70M
FCF Per Share	1.27

Margins

Gross margin is 34.52%, with operating and profit margins of 4.68% and -1.24%.

Gross Margin	34.52%
Operating Margin	4.68%
Pretax Margin	-0.96%
Profit Margin	-1.24%
EBITDA Margin	13.63%
EBIT Margin	4.68%
FCF Margin	11.04%

Dividends & Yields

This stock pays an annual dividend of 0.50, which amounts to a dividend yield of 5.42%.

Dividend Per Share	0.50
Dividend Yield	5.42%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.47%
Shareholder Yield	4.96%
Earnings Yield	-1.54%
FCF Yield	13.69%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

medmix AG has an Altman Z-Score of 1.91 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.91
Piotroski F-Score	5